![Badreddin Edris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Badreddin Edris
Fondateur chez
EDGEWISE THERAPEUTICS, INC.
Fortune : 804 692 $ au 30/09/2026
Profil
Badreddin Edris was the founder of Silverback Therapeutics, Inc., founded in 2016, and served as Chief Business Officer in 2018.
Dr. Edris is the founder of Edgewise Therapeutics, Inc., founded in 2017, and holds the title of Independent Non-Executive Director since 2021.
Dr. Edris is the founder of Beeline Medicines Corp., founded in 2025, and holds the titles of President & Chief Operating Officer starting in 2025.
Former jobs include Principal at Genentech Ventures, Inc., Principal at Mission Bay Capital Management, Inc., Chief Operating Officer at Springworks Therapeutics, Inc. from 2021 to 2025, and Principal at OrbiMed Advisors LLC from 2014 to 2018.
Education history includes a graduate degree from Stanford University in 2009, an undergraduate degree from Weber State University in 2007, and a doctorate from Stanford University School of Medicine in 2012.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 19 820 ( 0,02 % ) | 804 692 $ | 30/09/2026 |
Postes actifs de Badreddin Edris
| Sociétés | Poste | Début |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Fondateur | 01/01/2017 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | 01/02/2026 |
Anciens postes connus de Badreddin Edris
| Sociétés | Poste | Fin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Directeur des opérations | 01/07/2025 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Corporate Officer/Principal | 01/11/2018 |
| ARS PHARMACEUTICALS, INC. | Fondateur | 01/09/2018 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures invests in companies located in the United States. The firm focuses on biopharmaceuticals and biotechnology sectors. It participates in early stage transactions. | Corporate Officer/Principal | - |
Formation de Badreddin Edris
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weber State University
 Weber State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genentech Ventures, Inc.
Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures invests in companies located in the United States. The firm focuses on biopharmaceuticals and biotechnology sectors. It participates in early stage transactions. | Finance |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It provides financing for early stage capital requirements. | Finance |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for treating cancer | Health Technology |
